Search

everythinglearnresearchcommunity

for

Search:↓

PRP injections effectively treat hair loss, with positive results in both monthly and every three months treatments.

New progesterone-based compounds can block male hormones.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

A new platinum complex was made and studied, which might help fight cancer better.

PRP shows promise for skin rejuvenation but needs more research.

Combining platelet-rich plasma, microneedling, and minoxidil improves hair growth.

The new composite material is safe and has anticoagulant properties.

Platelet-rich plasma (PRP) shows promise in military medicine but its effectiveness varies.

Spanish speakers with limited English search most for "pigmentation/dark spots."

The project developed and tested a method using plasma rich platelets to treat hair loss.

PRP is effective for skin rejuvenation, hair restoration, and acne scar treatment.

Most patients with PCOS were prescribed medroxyprogesterone acetate or oral contraceptives, with some experiencing side effects or needing prescription changes.

Healthy aging can be promoted through physical activity, lifestyle changes, and certain treatments.

PRP use in skin care and plastic surgery is growing, especially in the U.S. and Italy.

Platelet lysate is better than fetal bovine serum for growing stem cells and healing wounds.

Single-spin PRP may be more effective for treating hair loss.

PRP's effectiveness for acne scars is uncertain.

The flexible fixed-sequence testing method allows for more effective evaluation of multiple goals in a clinical trial while controlling the risk of false positives.

PLX, a tomato extract mix, may help treat prostate issues like BPH.

Combining minoxidil and PRP is more effective for hair growth than using either alone.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

The ABHRS held a test in Capri, Italy.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.